Literature DB >> 26424945

Noncirrhotic hyperammonemia causing relapsing altered mental status.

Chibuzo Clement Odigwe1, Binod Khatiwada1, Christopher Holbrook1, Ifeoma Sylvia Ekeh1, Chukwuemeka Uzoka1, Isaac Ikwu1, Bishwas Upadhyay1.   

Abstract

Hyperammonemia is a recognized cause of encephalopathy. However, it is commonly seen in patients with liver disease. The clinical entity of noncirrhotic hyperammonemia is now being increasingly recognized. We report a man who presented to our hospital with relapsing altered mental status later diagnosed as noncirrhotic hyperammonemia.

Entities:  

Year:  2015        PMID： 26424945      PMCID： PMC4569228          DOI： 10.1080/08998280.2015.11929312

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  10 in total

1.  Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy.

Authors:  N D Hawkes; G A Thomas; A Jurewicz; O M Williams; C E Hillier; I N McQueen; G Shortland
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

Review 2.  Adult nonhepatic hyperammonemia: a case report and differential diagnosis.

Authors:  Jamie Nicole LaBuzetta; Jay Z Yao; Daniel L Bourque; Justin Zivin
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

3.  Fatal hyperammonemic encephalopathy after gastric bypass surgery.

Authors:  Andrew Fenves; C Richard Boland; Rita Lepe; Paulino Rivera-Torres; Stuart Jon Spechler
Journal:  Am J Med       Date:  2008-01       Impact factor: 4.965

4.  Transient hyperammonaemia in a patient with confusion: challenges with the differential diagnosis.

Authors:  Peter Lawrence Zaki Labib; Stevan Wing; Angshu Bhowmik
Journal:  BMJ Case Rep       Date:  2011-09-04

5.  High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.

Authors:  K H Yeh; A L Cheng
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.

Authors:  Louise Nott; Timothy J Price; Ken Pittman; Kevin Patterson; Janice Fletcher
Journal:  Leuk Lymphoma       Date:  2007-09

7.  Sodium valproate-related hyperammonaemic encephalopathy.

Authors:  Emily Jane Pegg; Fawad Zaman
Journal:  BMJ Case Rep       Date:  2014-04-10

8.  Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt.

Authors:  Shari S Rogal; Angela Hu; Rupal Bandi; Obaid Shaikh
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  Unusual causes of hyperammonemia in the ED.

Authors:  Te-I Weng; Frank Fuh-Yuan Shih; Wen-Jone Chen
Journal:  Am J Emerg Med       Date:  2004-03       Impact factor: 2.469

10.  Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: a case report and an update.

Authors:  S Vivekanandan; S Dinesh Nayak
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383
  10 in total
  4 in total

Review 1.  Cause for Confusion: Noncirrhotic Hyperammonemic Encephalopathy.

Authors:  Avash Kalra; J P Norvell
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-06-30

2.  Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.

Authors:  Massimiliano Allegritti; Benedetta Enrico; Emanuela Basile; Lara de Vito; Antonino Morabito; Roberto Cirocchi; Michela Giustozzi; Giovanni Passalacqua
Journal:  Dig Dis Sci       Date:  2020-04       Impact factor: 3.199

3.  Undiagnosed Wilson's Disease and Fibromyalgia Masking Bowel Perforation.

Authors:  Tyler Culpepper; Amar H Kelkar
Journal:  Cureus       Date:  2021-02-23

4.  A case of anti-VGKC antibody encephalitis and prolonged encephalopathy despite spontaneous resolution of imaging abnormalities.

Authors:  Victoria Novoselova; Vikas Kumar; Niranjan N Singh; Alexandre Lacasse
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.